(VIANEWS) - Potrero Capital Research LLC (CCB), China Petroleum & Chemical (SNP), General Motors (GM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Potrero Capital Research LLC (CCB)
163.7% sales growth and 15.35% return on equity
Potrero Capital Research LLC's sales growth this year is anticipated to be 131.8% and 42.6% for next year.
Year-on-year quarterly revenue growth grew by 92.1%, now sitting on 116.01M for the twelve trailing months.
Volume
Today's last reported volume for Potrero Capital Research LLC is 26882 which is 33.52% below its average volume of 40438.
Potrero Capital Research LLC's sales growth is a negative 0% for the current quarter and 163.7% for the next. The company's growth estimates for the present quarter and the next is a negative 3.6% and 14.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.35%.
Volatility
Potrero Capital Research LLC's last day, last week, and last month's current intraday variation average was 3.94%, 1.72%, and 1.41%, respectively.
Potrero Capital Research LLC's highest amplitude of average volatility was 3.21% (day), 2.18% (last week), and 3.13% (last month), respectively.
Potrero Capital Research LLC's Stock Yearly Top and Bottom Value
Potrero Capital Research LLC's stock is valued at $38.54 at 16:22 EST, way below its 52-week high of $54.41 and way above its 52-week low of $26.80.
Potrero Capital Research LLC's Moving Average
Potrero Capital Research LLC's worth is above its 50-day moving average of $38.34 and way below its 200-day moving average of $43.02.2. China Petroleum & Chemical (SNP)
64.5% sales growth and 12.96% return on equity
China Petroleum & Chemical Corporation is an energy and chemical corporation that engages in oil, gas and chemical operations in China's People's Republic of China.
China Petroleum & Chemical's sales growth this year is anticipated to be 39.6% and 7% for next year.
Year-on-year quarterly revenue growth grew by 43.1%, now sitting on 2.33T for the twelve trailing months.
Volume
Today's last reported volume for China Petroleum & Chemical is 153658 which is 26.06% below its average volume of 207818.
China Petroleum & Chemical's sales growth for the next quarter is 64.5%. The company's growth estimates for the present quarter and the next is 60.6% and 158%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.96%.
Volatility
China Petroleum & Chemical's last day, last week, and last month's current intraday variation average was 0.37%, 1.21%, and 1.47%, respectively.
China Petroleum & Chemical's highest amplitude of average volatility was 1.27% (day), 1.45% (last week), and 1.73% (last month), respectively.
China Petroleum & Chemical's Stock Yearly Top and Bottom Value
China Petroleum & Chemical's stock is valued at $47.29 at 16:22 EST, way below its 52-week high of $58.40 and above its 52-week low of $43.18.
China Petroleum & Chemical's Moving Average
China Petroleum & Chemical's worth is under its 50-day moving average of $48.78 and under its 200-day moving average of $50.33.3. General Motors (GM)
44.7% sales growth and 16.03% return on equity
General Motors Company builds and sells automobiles and trucks worldwide.
General Motors's sales growth this year is anticipated to be 20.6% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 130.51B for the twelve trailing months.
Volume
Today's last reported volume for General Motors is 10737000 which is 35.45% below its average volume of 16634800.
News about General Motors(GM) today
- According to today's article on FXStreet, "The major automotive news for the day was that General Motors (NYSE: GM) missed for the quarter on both the top and bottom line. "
- According to today's article on FXStreet, "Electric vehicle stocks fell across the board on Tuesday as legacy automaker General Motors (NYSE:GM) missed on its second quarter earnings. "
General Motors's sales growth for the next quarter is 44.7%. The company's growth estimates for the current quarter and the next is a negative 16.2% and 11.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.03%.
Volatility
General Motors's last day, last week, and last month's current intraday variation average was 3.54%, 1.48%, and 2.14%, respectively.
General Motors's highest amplitude of average volatility was 3.15% (day), 2.73% (last week), and 3.88% (last month), respectively.
General Motors's Stock Yearly Top and Bottom Value
General Motors's stock is valued at $34.73 at 16:22 EST, way under its 52-week high of $67.21 and way above its 52-week low of $30.33.
General Motors's Moving Average
General Motors's value is under its 50-day moving average of $34.74 and way below its 200-day moving average of $47.45.4. Intuitive Surgical (ISRG)
14.7% sales growth and 14.88% return on equity
Intuitive Surgical, Inc. and its subsidiaries design, manufacture, and market da Vinci surgical system and associated instruments and accessories both in the United States as well internationally.
Intuitive Surgical's sales growth this year is expected to be 11.7% and 12.6% for next year.
Year-on-year quarterly revenue growth grew by 15.1%, now sitting on 5.91B for the twelve trailing months.
Volume
Today's last reported volume for Intuitive Surgical is 2094190 which is 2.28% below its average volume of 2143150.
Intuitive Surgical's sales growth for the next quarter is 14.7%. The company's growth estimates for the current quarter and the next is a negative 8.4% and 2.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.88%.
Volatility
Intuitive Surgical's last day, last week, and last month's current intraday variation average was 1.10%, 3.08%, and 1.89%, respectively.
Intuitive Surgical's highest amplitude of average volatility was 2.73% (day), 4.00% (last week), and 3.36% (last month), respectively.
Intuitive Surgical's Stock Yearly Top and Bottom Value
Intuitive Surgical's stock is valued at $225.34 at 16:22 EST, way below its 52-week high of $369.69 and way above its 52-week low of $186.83.
Intuitive Surgical's Moving Average
Intuitive Surgical's value is higher than its 50-day moving average of $210.89 and way below its 200-day moving average of $284.13.5. Tennant (TNC)
11.3% sales growth and 11.53% return on equity
Tennant Company manufactures and markets floor-cleaning equipment throughout the Americas and Europe.
Tennant's sales growth this year is expected to be 5.1% and 2.9% for next year.
Year-on-year quarterly revenue growth declined by 2%, now sitting on 1.09B for the twelve trailing months.
Volume
Today's last reported volume for Tennant is 21454 which is 63.96% below its average volume of 59544.
Tennant's sales growth for the next quarter is 11.3%. The company's growth estimates for the ongoing quarter and the next is a negative 27.1% and negative -3.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.53%.
Volatility
Tennant's last day, last week, and last month's current intraday variation average was 0.19%, 0.25%, and 1.14%, respectively.
Tennant's highest amplitude of average volatility was 1.42% (day), 1.37% (last week), and 2.08% (last month), respectively.
Tennant's Stock Yearly Top and Bottom Value
Tennant's stock is valued at $65.53 at 16:22 EST, way below its 52-week high of $85.33 and way higher than its 52-week low of $54.90.
Tennant's Moving Average
Tennant's value is higher than its 50-day moving average of $62.08 and way under its 200-day moving average of $74.52.6. Zoetis (ZTS)
8% sales growth and 47.76% return on equity
Zoetis Inc. develops, produces, markets, and sells diagnostic and animal medicine products, vaccines and other health products within the United States as well as internationally.
Zoetis's sales growth this year is anticipated to be 15.1% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 7.62B for the twelve trailing months.
Volume
Today's last reported volume for Zoetis is 949840 which is 54.49% below its average volume of 2087420.
Zoetis's sales growth is a negative 0% for the current quarter and 8% for the next. The company's growth estimates for the present quarter and the next is 0.9% and 11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.76%.
Volatility
Zoetis's last day, last week, and last month's current intraday variation average was 0.69%, 1.23%, and 1.93%, respectively.
Zoetis's highest amplitude of average volatility was 1.58% (day), 2.11% (last week), and 2.28% (last month), respectively.
Zoetis's Stock Yearly Top and Bottom Value
Zoetis's stock is valued at $177.57 at 16:22 EST, way under its 52-week high of $231.91 and way higher than its 52-week low of $141.41.